The Pharma cold chain market reached USD 6.67 billion in 2025, growing to USD 6.93 billion in 2026 at a 3.83% CAGR, fuelled by biologics, vaccines, and mRNA therapies demanding ultra-low temperatures. Key trends include AI/IoT for predictive excursion prevention, blockchain transparency, and sustainable packaging amid ESG mandates, with India's logistics sector at USD 0.57 billion expanding rapidly to support biosimilars. Projections emphasize resilient networks against global volatility, positioning India as the "Pharmacy of the World" targeting USD 74.5 billion by 2033